Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial (Q44350321)
Jump to navigation
Jump to search
scientific article published on 8 November 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial |
scientific article published on 8 November 2011 |
Statements
1 reference
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial (English)
1 reference
Anne Szarewski
1 reference
Cosette M Wheeler
1 reference
Jorma Paavonen
1 reference
F Xavier Bosch
2 references
S Rachel Skinner
2 references
Suzanne M Garland
1 reference
Paulo Naud
1 reference
Song-Nan Chow
1 reference
Henry Kitchener
1 reference
Unnop Jaisamrarn
1 reference
Genara Limson
1 reference
Barbara Romanowski
1 reference
Fred Y Aoki
1 reference
Willy A J Poppe
1 reference
Toufik Zahaf
1 reference
Dominique Descamps
1 reference
HPV PATRICIA Study Group
1 reference
Júlio C Teixeira
1 reference
Tino F Schwarz
1 reference
Diane M Harper
1 reference
Warner Huh
1 reference
Karin Hardt
1 reference
Gary Dubin
1 reference
Matti Lehtinen
1 reference
8 November 2011
1 reference
1 reference
13
1 reference
1
1 reference
100-110
1 reference
Identifiers
1 reference
1 reference